SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001346302-19-000035
Filing Date
2019-10-01
Accepted
2019-10-01 16:03:21
Documents
3
Period of Report
2019-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kofficerappointment.htm 8-K 41397
2 EXHIBIT 99.1 exhibit9918-kofficerappoin.htm EX-99.1 12223
3 xerislpharmrgba10.jpg GRAPHIC 74582
  Complete submission text file 0001346302-19-000035.txt   157514
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38536 | Film No.: 191129154
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences